Developer docs
API playgroundTry for free, no card

Search company profiles

Callan JMB

Full company profile

uuid00021xr

Namestring
Callan JMB
Legal namestring
Callan JMB Inc.
Websiteurl
callanjmb.com
Company typeenum
Public
Founded yearint
2006
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersSpring Branch, United States
HQ citystring
Spring Branch
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cold chain logistics, specialty packaging, emergency preparedness, pharmaceutical fulfillment, temperature-controlled shipping
Industry5 codes
1Vaccine & Public Health Immunization Cold Chain Logistics
CodeTLAIAIADPrimaryYes
2Cryogenic & Ultra-Low Temperature Logistics (-80°C, LN2 Dry Shipper)
CodeTLAIAIAKPrimaryNo
3Life Sciences Cold Chain Logistics (2–8°C, -20°C, -80°C)
CodeHLAGAMAAPrimaryNo
4Pharmaceutical & Medical Device Packaging (GMP, Tamper-Evident, Cold-Chain Packs)
CodeTLAIAGAIPrimaryNo
5Cold-Chain Packaging & Pack-Out Services (Gel Packs, Dry Ice, Insulated Shippers)
CodeTLAIAGAKPrimaryNo
NAICS code1 code
  • Refrigerated Warehousing and Storage493120
SIC code1 code
  • Refrigeration & Service Industry Machinery3580
Product category
Cold Chain Pharmaceutical Logistics
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Government Logistics Contracts
TypeManaged Services
Description

Long-term contracts with government agencies for emergency preparedness, cold chain logistics, and public health response services. Includes contracts with Oregon Health Authority, City of Chicago, Texas DSHS. Currently generating approximately $175,000 per month from a major public sector engagement.

callanjmb.com
2Specialty Packaging Leasing
TypeSubscription Recurring
Description

Leasing model for reusable thermal shippers instead of outright sales. Enables clients to leverage high-end shipping solutions without capital expenditure. Shippers travel back and forth 12-15 times per year.

callanjmb.com
3Fulfillment and Logistics Services
TypeProfessional Services
Description

End-to-end fulfillment services for healthcare, food, and emergency response industries including storage, distribution, kitting, recovery and redistribution services.

callanjmb.com
4Manufacturing Oversight Services
TypeManaged Services
Description

Partnership with Attune Biotech for manufacturing oversight, quality assurance, and federal deployment operations. Projected $25-45 million revenue share for Callan JMB over five years from $50-75 million combined partnership revenue.

quiverquant.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Supply Chain, Infrastructure, Marketing or Sales
Pricing details1 tier
1Public Sector Infrastructure Contract
ModelSubscriptionBilling cadenceMonthly
Notes

$175,000 per month for six months ($1.05 million total) covering specialized storage, cold chain logistics, and emergency management operations.

stocktitan.net
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 5 records shown
1Sentry
Description

Real-time monitoring system for tracking shipment location, temperature, and condition from start to finish with 24/7 monitoring and instant alerts.

callanjmb.com
+4 more records
Core offering1 text field

Callan JMB provides end-to-end cold chain logistics, specialty reusable packaging, emergency preparedness and response, and product fulfillment services for pharmaceutical, diagnostic, healthcare, and food customers. Its offering combines proprietary technology (Sentry monitoring, IMS inventory management, Data Loggers, SHIP2Q sanitization, VIP thermal shippers) with cGMP-compliant warehousing, distribution, and managed logistics for sensitive products that require validated temperature control and regulatory compliance.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 99.9% shipment success rate - only 3 compromised shipments out of 3 million+ since 2007
+4 more records
Product overview1 text field

Callan JMB is a vertically-integrated logistics company offering a unified platform of proprietary technologies and services for the healthcare, pharmaceutical, and emergency response industries. The core portfolio includes: Sentry (real-time monitoring system), IMS (inventory management system), Data Loggers (precision temperature control), and SHIP2Q (sustainable packaging with reclamation). These are complemented by Specialty Packaging (reusable thermal shippers), Fulfillment Services, and Emergency Preparedness & Response capabilities. The company also operates Atlas Complex, a planned pharmaceutical campus in Alabama. Recent expansions include food sampling logistics and VFC authorization for pediatric vaccine distribution in Oregon.

Product and service2 records
1Sentry Monitoring System
CategoryReal-time Supply Chain Monitoring Software
Description

Real-time monitoring platform providing 24/7/365 tracking of temperature, humidity, location, and security status for temperature-sensitive goods, with instant alerts for threshold breaches. Used by pharmaceutical manufacturers, government agencies, and healthcare systems requiring validated supply chain visibility.

2IMS (Inventory Management System)
Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierStrategicTypeTechnology or IntegrationAnnounced on2026-04-20
Description

First on-site international partner for the Atlas Complex campus in Marion, Alabama. Walker's Pharmaceuticals will operate within the campus to support pharmaceutical onshoring initiatives.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-27
Description

Collaboration involving DifGen Pharmaceuticals, Aveva Drug Delivery Systems, Biostax Corp (Attune Biotech), and SGP Holdings to support scale-up of Lodonal immune platform for Phase 2b/3 clinical development. Callan JMB provides validation of manufacturing, quality, and supply chain operations.

3Attune Biotech (Biostax Corp)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-15
Description

Strategic teaming agreement where Callan JMB serves as independent third-party overseer of Attune's manufacturing, quality assurance, and deployment operations for federal procurement. Enables immediate federal deployment capability by leveraging existing government infrastructure. Anticipated $50-75 million combined revenue over five years with Callan JMB share of $25-45 million.

quiverquant.com
Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2025-05-21
Description

Joint venture to strengthen U.S. supply chain for vital health, wellness, and longevity products. Combines Callan JMB's logistics expertise with Revival Health's product development capabilities.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-05-21
Description

Partnership to deliver life-saving cancer diagnostic kits through Callan JMB's logistics and fulfillment expertise.

Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Partnership with third-largest blood bank organization in the world. Callan JMB provides specialized packaging ensuring safe transport of millions of tests for BioBridge Global's operations.

Strategic tierStrategicTypeChannel Partner/ Reseller/ Distributor
Description

Supply of specialty shippers to the Defense Logistics Agency for military logistics support.

Strategic tierStrategicTypeChannel Partner/ Reseller/ Distributor
Description

Partnership for global health initiatives, providing logistics support for international pharmaceutical and vaccine distribution.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Partnership to provide sustainable logistics and fulfillment solutions to Complete Group Services members.

Recent move10 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Pelican BioThermal manufactures reusable and single-use temperature-controlled shippers for life sciences and pharmaceuticals. Directly competes with Callan JMB's VIP reusable thermal shippers and SHIP2Q program in the cold chain packaging market.

TypeDirect peer
Description

Sonoco ThermoSafe is a leading provider of temperature-assured packaging for pharmaceuticals, biologics, and vaccines. Competes head-to-head with Callan JMB's VIP reusable shippers across reusable and parcel cold-chain formats.

TypeDirect peer
Description

Cold Chain Technologies designs and produces thermal packaging solutions for pharma, biotech, and clinical trial logistics. Closely comparable product offering to Callan JMB's specialty packaging line, serving similar pharmaceutical customers.

TypeDirect peer
Description

CSafe Global provides active and passive temperature-controlled container solutions for the pharmaceutical and life sciences cold chain. Competes directly with Callan JMB in reusable thermal shippers and active container systems for pharma.

TypeDirect peer
Description

va-Q-tec produces high-performance vacuum insulation panels and reusable thermal shipping containers for pharmaceutical cold chain. Directly comparable technology and product offering to Callan JMB's VIP reusable shippers.

TypeDirect peer
Description

World Courier is a specialty logistics provider focused on time- and temperature-sensitive pharmaceutical shipments, owned by Cencora. Directly comparable in pharmaceutical cold chain distribution and clinical trial logistics services.

TypeBroad incumbent
Description

DHL Supply Chain operates global life sciences and healthcare cold chain logistics including warehousing, transport, and clinical trial support. A scaled incumbent offering overlapping capabilities but as part of a much broader contract logistics portfolio.

TypeBroad incumbent
Description

UPS Healthcare provides temperature-controlled shipping, cold chain warehousing, and pharma logistics globally. A broad incumbent with overlapping cold chain capabilities but operates as part of UPS's larger integrated parcel and supply chain network.

TypeBroad incumbent
Description

FedEx Custom Critical provides time- and temperature-sensitive shipping for healthcare and life sciences including shipments requiring refrigerated or frozen environments. Broad incumbent competing in cold chain services, though not specialized in cold chain packaging.

TypeBroad incumbent
Description

McKesson is one of the largest pharmaceutical distributors in the U.S. with extensive cold chain capabilities and government health agency relationships. Broad incumbent with overlap in pharmaceutical logistics, though primarily a distribution rather than specialty cold chain company.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers12 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Callan JMB

Cold Chain Pharmaceutical Logisticscallanjmb.com

Callan JMB firmographics

Firmographics
Name
Callan JMB
Legal name
Callan JMB Inc.
Website
https://callanjmb.com
Company type
Public
Founded year
2006
Operating status
Operating
Headcount range
51–100 employees
Ownership category
akta.pro rank

Callan JMB industry classification

Industry
Product category
Cold Chain Pharmaceutical Logistics
NAICS
Refrigerated Warehousing and Storage (493120)
SIC
Refrigeration & Service Industry Machinery (3580)
akta.pro primary industry
Vaccine & Public Health Immunization Cold Chain Logistics (TLAIAIAD)
akta.pro secondary industries
Cryogenic & Ultra-Low Temperature Logistics (-80°C, LN2 Dry Shipper) (TLAIAIAK), Life Sciences Cold Chain Logistics (2–8°C, -20°C, -80°C) (HLAGAMAA), Pharmaceutical & Medical Device Packaging (GMP, Tamper-Evident, Cold-Chain Packs) (TLAIAGAI), Cold-Chain Packaging & Pack-Out Services (Gel Packs, Dry Ice, Insulated Shippers) (TLAIAGAK)

Keywords

  • Cold chain logistics
  • Specialty packaging
  • Emergency preparedness
  • Pharmaceutical fulfillment
  • Temperature-controlled shipping

Where Callan JMB is headquartered

Location

Headquarters

HQ city
Spring Branch
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Callan JMB business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Supply Chain, Infrastructure, Marketing or Sales

Revenue model

  1. Government Logistics Contracts: Long-term contracts with government agencies for emergency preparedness, cold chain logistics, and public health response services. Includes contracts with Oregon Health Authority, City of Chicago, Texas DSHS. Currently generating approximately $175,000 per month from a major public sector engagement.
  2. Specialty Packaging Leasing: Leasing model for reusable thermal shippers instead of outright sales. Enables clients to leverage high-end shipping solutions without capital expenditure. Shippers travel back and forth 12-15 times per year.
  3. Fulfillment and Logistics Services: End-to-end fulfillment services for healthcare, food, and emergency response industries including storage, distribution, kitting, recovery and redistribution services.
  4. Manufacturing Oversight Services: Partnership with Attune Biotech for manufacturing oversight, quality assurance, and federal deployment operations. Projected $25-45 million revenue share for Callan JMB over five years from $50-75 million combined partnership revenue.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyPublic Sector Infrastructure Contract

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Callan JMB product offering

Product offering

Core offering

Callan JMB provides end-to-end cold chain logistics, specialty reusable packaging, emergency preparedness and response, and product fulfillment services for pharmaceutical, diagnostic, healthcare, and food customers. Its offering combines proprietary technology (Sentry monitoring, IMS inventory management, Data Loggers, SHIP2Q sanitization, VIP thermal shippers) with cGMP-compliant warehousing, distribution, and managed logistics for sensitive products that require validated temperature control and regulatory compliance.

Product overview

Callan JMB is a vertically-integrated logistics company offering a unified platform of proprietary technologies and services for the healthcare, pharmaceutical, and emergency response industries. The core portfolio includes: Sentry (real-time monitoring system), IMS (inventory management system), Data Loggers (precision temperature control), and SHIP2Q (sustainable packaging with reclamation). These are complemented by Specialty Packaging (reusable thermal shippers), Fulfillment Services, and Emergency Preparedness & Response capabilities. The company also operates Atlas Complex, a planned pharmaceutical campus in Alabama. Recent expansions include food sampling logistics and VFC authorization for pediatric vaccine distribution in Oregon.

Differentiator

Problem solved

Functional benefit

Brands

  • Sentry: Real-time monitoring system for tracking shipment location, temperature, and condition from start to finish with 24/7 monitoring and instant alerts.
  • IMS
  • Data Loggers
  • SHIP2Q
  • Atlas Complex

Products and services

  • Sentry Monitoring System Real-time monitoring platform providing 24/7/365 tracking of temperature, humidity, location, and security status for temperature-sensitive goods, with instant alerts for threshold breaches. Used by pharmaceutical manufacturers, government agencies, and healthcare systems requiring validated supply chain visibility.
  • IMS (Inventory Management System)

Quantifiable outcome

  • 99.9% shipment success rate - only 3 compromised shipments out of 3 million+ since 2007
  • +4 more outcomes

Companies that use Callan JMB

Customer profile

Named customers12 records

Segments6 records

Ideal customer profiles4 records

Callan JMB technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature6 records

Callan JMB partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered strategic, core and minor.

  • Walker's PharmaceuticalsstrategicTechnology or Integration · 20 April 2026First on-site international partner for the Atlas Complex campus in Marion, Alabama. Walker's Pharmaceuticals will operate within the campus to support pharmaceutical onshoring initiatives.
  • DifGen PharmaceuticalscoreStrategic or Co-development Partner · 27 March 2026Collaboration involving DifGen Pharmaceuticals, Aveva Drug Delivery Systems, Biostax Corp (Attune Biotech), and SGP Holdings to support scale-up of Lodonal immune platform for Phase 2b/3 clinical development. Callan JMB provides validation of manufacturing, quality, and supply chain operations.
  • Attune Biotech (Biostax Corp)coreStrategic or Co-development Partner · 15 January 2026Strategic teaming agreement where Callan JMB serves as independent third-party overseer of Attune's manufacturing, quality assurance, and deployment operations for federal procurement. Enables immediate federal deployment capability by leveraging existing government infrastructure. Anticipated $50-75 million combined revenue over five years with Callan JMB share of $25-45 million.
  • Revival HealthstrategicStrategic or Co-development Partner · 21 May 2025Joint venture to strengthen U.S. supply chain for vital health, wellness, and longevity products. Combines Callan JMB's logistics expertise with Revival Health's product development capabilities.
  • VibrantWorksminorStrategic or Co-development Partner · 21 May 2025Partnership to deliver life-saving cancer diagnostic kits through Callan JMB's logistics and fulfillment expertise.
  • BioBridge GlobalstrategicStrategic or Co-development PartnerPartnership with third-largest blood bank organization in the world. Callan JMB provides specialized packaging ensuring safe transport of millions of tests for BioBridge Global's operations.
  • Defense Logistics Agency (DLA)strategicChannel Partner/ Reseller/ DistributorSupply of specialty shippers to the Defense Logistics Agency for military logistics support.
  • World Health Organization (WHO)strategicChannel Partner/ Reseller/ DistributorPartnership for global health initiatives, providing logistics support for international pharmaceutical and vaccine distribution.
  • Complete Group Services LLCminorChannel Partner/ Reseller/ DistributorPartnership to provide sustainable logistics and fulfillment solutions to Complete Group Services members.

Scale indicators10 records

Recent moves10 records

Expansion highlights6 records

Callan JMB competitors and assessment

Company assessment

Direct peers

  • Pelican BioThermal: Pelican BioThermal manufactures reusable and single-use temperature-controlled shippers for life sciences and pharmaceuticals. Directly competes with Callan JMB's VIP reusable thermal shippers and SHIP2Q program in the cold chain packaging market.
  • Sonoco ThermoSafe: Sonoco ThermoSafe is a leading provider of temperature-assured packaging for pharmaceuticals, biologics, and vaccines. Competes head-to-head with Callan JMB's VIP reusable shippers across reusable and parcel cold-chain formats.
  • Cold Chain Technologies: Cold Chain Technologies designs and produces thermal packaging solutions for pharma, biotech, and clinical trial logistics. Closely comparable product offering to Callan JMB's specialty packaging line, serving similar pharmaceutical customers.
  • CSafe Global: CSafe Global provides active and passive temperature-controlled container solutions for the pharmaceutical and life sciences cold chain. Competes directly with Callan JMB in reusable thermal shippers and active container systems for pharma.
  • va-Q-tec: va-Q-tec produces high-performance vacuum insulation panels and reusable thermal shipping containers for pharmaceutical cold chain. Directly comparable technology and product offering to Callan JMB's VIP reusable shippers.
  • World Courier (Cencora): World Courier is a specialty logistics provider focused on time- and temperature-sensitive pharmaceutical shipments, owned by Cencora. Directly comparable in pharmaceutical cold chain distribution and clinical trial logistics services.

Broad incumbents

  • DHL Supply Chain Life Sciences: DHL Supply Chain operates global life sciences and healthcare cold chain logistics including warehousing, transport, and clinical trial support. A scaled incumbent offering overlapping capabilities but as part of a much broader contract logistics portfolio.
  • UPS Healthcare: UPS Healthcare provides temperature-controlled shipping, cold chain warehousing, and pharma logistics globally. A broad incumbent with overlapping cold chain capabilities but operates as part of UPS's larger integrated parcel and supply chain network.
  • FedEx Custom Critical: FedEx Custom Critical provides time- and temperature-sensitive shipping for healthcare and life sciences including shipments requiring refrigerated or frozen environments. Broad incumbent competing in cold chain services, though not specialized in cold chain packaging.
  • McKesson Corporation: McKesson is one of the largest pharmaceutical distributors in the U.S. with extensive cold chain capabilities and government health agency relationships. Broad incumbent with overlap in pharmaceutical logistics, though primarily a distribution rather than specialty cold chain company.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Callan JMB social profiles

Digital presence

Callan JMB compliance and trust

Trust signal

Compliance2 records

Callan JMB financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Callan JMB leadership team

Management profile

Number of profiles

Profiles5 records

Callan JMB subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Callan JMB funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Callan JMB M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Callan JMB

What does Callan JMB do?

Callan JMB provides end-to-end cold chain logistics, specialty reusable packaging, emergency preparedness and response, and product fulfillment services for pharmaceutical, diagnostic, healthcare, and food customers. Its offering combines proprietary technology (Sentry monitoring, IMS inventory management, Data Loggers, SHIP2Q sanitization, VIP thermal shippers) with cGMP-compliant warehousing, distribution, and managed logistics for sensitive products that require validated temperature control and regulatory compliance.

Is Callan JMB a public or private company?

Callan JMB is a public company. It is classified as public and is currently operating.

When was Callan JMB founded?

Callan JMB was founded in 2006. It employs 51 to 100 people.

Where is Callan JMB based?

Callan JMB is headquartered in Spring Branch, United States, in the North America region.

How does Callan JMB make money?

Four revenue lines are on record. Government Logistics Contracts are the primary driver. The others are specialty Packaging Leasing, fulfillment and Logistics Services and manufacturing Oversight Services.

Who are Callan JMB's main competitors?

Direct peers on record are Pelican BioThermal, Sonoco ThermoSafe, Cold Chain Technologies, CSafe Global, va-Q-tec and World Courier (Cencora). Broad incumbents are DHL Supply Chain Life Sciences, UPS Healthcare, FedEx Custom Critical and McKesson Corporation.

Does Callan JMB have an API?

No public API is recorded for Callan JMB.

What industry is Callan JMB in?

Callan JMB's product category is Cold Chain Pharmaceutical Logistics. Its primary akta.pro industry code is TLAIAIAD, Vaccine & Public Health Immunization Cold Chain Logistics, with a secondary code of TLAIAIAK, Cryogenic & Ultra-Low Temperature Logistics (-80°C, LN2 Dry Shipper). Its NAICS code is 493120 and its SIC code is 3580.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Markets DailyFinancial Contrast: Callan JMB (NASDAQ:CJMB) versus Forward Air (NASDAQ:FWRD)Forward Air beats Callan JMB on 9 of 14 factors, including valuation and analyst ratings. Forward Air trades at a lower P/E ratio and has a consensus price target of $24.50, implying 55.36% upside. Callan JMB has higher earnings but lower revenue and a negative beta of -0.53.American Banking and Market NewsReviewing Air T (NASDAQ:AIRT) & Callan JMB (NASDAQ:CJMB)Air T and Callan JMB are compared on profitability, valuation, and analyst ratings. Air T has higher revenue and earnings, while Callan JMB trades at a lower price-to-earnings ratio. Air T beats Callan JMB on 10 of 12 factors.American Banking and Market NewsReviewing Forward Air (NASDAQ:FWRD) and Callan JMB (NASDAQ:CJMB)Forward Air beats Callan JMB on 9 of 14 factors, including analyst ratings and valuation. Forward Air has a consensus target price of $26.00, implying 72.53% upside, while Callan JMB has a 1.00 rating score. Forward Air is trading at a lower price-to-earnings ratio, making it the more affordable stock.Markets DailyCallan JMB (NASDAQ:CJMB) versus ETS (NASDAQ:ETS) Head to Head SurveyA head-to-head comparison of ETS and Callan JMB evaluates nine factors including dividends, risk, analyst ratings, institutional ownership, profitability, valuation, and earnings. ETS beats Callan JMB on six of the nine factors, with ETS trading at a lower price-to-earnings ratio and higher earnings per share.American Banking and Market NewsWall Street Zen Downgrades Callan JMB (NASDAQ:CJMB) to SellWall Street Zen downgraded Callan JMB to a Sell rating, while Weiss Ratings restated a Sell (e+) rating. The company reported a Q2 loss of $0.22 per share on revenue of $1.38 million, and Bard Associates bought a new stake of 229,250 shares.Ticker ReportAnalyzing Air T (NASDAQ:AIRT) & Callan JMB (NASDAQ:CJMB)Air T and Callan JMB are compared on analyst ratings, profitability, and valuation. Air T beats Callan JMB on 10 of 12 factors, with higher revenue and earnings, while Callan JMB trades at a lower price-to-earnings ratio. Air T has higher institutional ownership, while Callan JMB has higher insider ownership.TradingViewCallan JMB's Mark Meller resigns from board and audit committeeMark Meller resigned from Callan JMB's board and as chair of the audit committee, effective August 26, 2026. The resignation relates to governance arrangements under an asset purchase and sale agreement with Reger Oil, Inc. A replacement will be nominated by holders of a majority of the company's Series A perpetual convertible preferred stock upon closing.Quiver QuantitativeCallan JMB Announces $12.5 Million Acquisition of Non-Operated Williston Basin Oil and Gas Interests from The Pfanenstiel Company | CJMB Stock NewsCallan JMB Inc. announced it has agreed to acquire a non-operated working interest in producing oil and gas properties in the Williston Basin from The Pfanenstiel Company for $12.5 million in cash, plus cost reimbursements. The deal covers 377 producing wells yielding about 150 BOE/day, with an independently estimated proved PV-10 of $48.1 million and projected annualized cash flow of roughly $2.5 million at $75 WTI. Closing is expected before October 1, 2026.YahooCallan Power to Acquire Williston Basin Non-Operated Oil and Gas Assets with $48 Million Proved PV-10 and $83 Million 3P PV-10 from The Pfanenstiel Company, Significantly Expanding Energy AssetsCallan JMB Inc. announced on Aug. 27, 2026 that its subsidiary Callan Power LLC has agreed to buy a non-operated working interest in Williston Basin oil and gas properties from The Pfanenstiel Company, LLC for $12.5 million in cash plus cost reimbursement. The deal covers 377 producing wells, about 150 BOE/day of net production, with an independent reserve report estimating $48.1 million in proved PV-10 and $82.7 million on total proved, probable and possible reserves. Closing is expected before Oct. 1, 2026.Stock TitanCallan JMB to Acquire Williston Assets for $12.5MCallan JMB, through its subsidiary Callan Power LLC, announced a definitive agreement to buy a non-operated working interest in Williston Basin oil and gas properties from The Pfanenstiel Company for $12.5 million in cash plus reimbursement of certain costs. The deal covers 377 producing wells, about 150 BOE/day, with proved PV-10 of $48.1 million and 3P PV-10 of $82.7 million, closing before October 1, 2026.